Search Results - "Golozar, Asieh"

Fasting Versus Nonfasting and Low-Density Lipoprotein Cholesterol Accuracy by Sathiyakumar, Vasanth, Park, Jihwan, Golozar, Asieh, Lazo, Mariana, Quispe, Renato, Guallar, Eliseo, Blumenthal, Roger S, Jones, Steven R, Martin, Seth S

“…BACKGROUND:Recent recommendations favoring nonfasting lipid assessment may affect low-density lipoprotein cholesterol (LDL-C) estimation. The novel method of…”
Get full text

Fatigability, Exercise Intolerance, and Abnormal Skeletal Muscle Energetics in Heart Failure by Weiss, Kilian, Schär, Michael, Panjrath, Gurusher S, Zhang, Yi, Sharma, Kavita, Bottomley, Paul A, Golozar, Asieh, Steinberg, Angela, Gerstenblith, Gary, Russell, Stuart D, Weiss, Robert G

“…Among central and peripheral factors contributing to exercise intolerance (EI) in heart failure (HF), the extent to which skeletal muscle (SM) energy metabolic…”
Get full text

STK11 (LKB1) mutations in metastatic NSCLC: Prognostic value in the real world by Shire, Norah J., Klein, Alyssa B., Golozar, Asieh, Collins, Jenna M., Fraeman, Kathy H., Nordstrom, Beth L., McEwen, Robert, Hembrough, Todd, Rizvi, Naiyer A.

“…Background Mutations in STK11 (STK11m) and frequently co-occurring KRAS mutations (KRASm/STK11m) are associated with poor survival in metastatic NSCLC (mNSCLC)…”
Get full text

FOUNTAIN: a modular research platform for integrated real-world evidence generation by Oberprieler, Nikolaus G, Pladevall-Vila, Manel, Johannes, Catherine, Layton, J Bradley, Golozar, Asieh, Lavallee, Martin, Liu, Fangfang, Kubin, Maria, Vizcaya, David

“…Real-world evidence (RWE) plays a key role in regulatory and healthcare decision-making, but the potentially fragmentated nature of generated evidence may…”
Get full text

White rice intake and incidence of type-2 diabetes: analysis of two prospective cohort studies from Iran by Golozar, Asieh, Khalili, Davood, Etemadi, Arash, Poustchi, Hossein, Fazeltabar, Akbar, Hosseini, Firoozeh, Kamangar, Farin, Khoshnia, Masoud, Islami, Farhad, Hadaegh, Farzad, Brennan, Paul, Boffetta, Paolo, Abnet, Christian C, Dawsey, Sanford M, Azizi, Fereidoun, Malekzadeh, Reza, Danaei, Goodarz

“…Refined grains and white rice have been associated with elevated risk of type 2 diabetes mellitus (T2DM). In this study, we sought to quantify the effect of…”
Get full text

Identification and Description of Reliable Evidence for 2016 American Academy of Ophthalmology Preferred Practice Pattern Guidelines for Cataract in the Adult Eye by Golozar, Asieh, Chen, Yujiang, Lindsley, Kristina, Rouse, Benjamin, Musch, David C, Lum, Flora, Hawkins, Barbara S, Li, Tianjing

“…Trustworthy clinical practice guidelines require reliable systematic reviews of the evidence to support recommendations. Since 2016, the American Academy of…”
Get more information

Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom by Recalde, Martina, Roel, Elena, Pistillo, Andrea, Sena, Anthony G., Prats-Uribe, Albert, Ahmed, Waheed-Ul-Rahman, Alghoul, Heba, Alshammari, Thamir M., Alser, Osaid, Areia, Carlos, Burn, Edward, Casajust, Paula, Dawoud, Dalia, DuVall, Scott L., Falconer, Thomas, Fernández-Bertolín, Sergio, Golozar, Asieh, Gong, Mengchun, Lai, Lana Yin Hui, Lane, Jennifer C. E., Lynch, Kristine E., Matheny, Michael E., Mehta, Paras P., Morales, Daniel R., Natarjan, Karthik, Nyberg, Fredrik, Posada, Jose D., Reich, Christian G., Rijnbeek, Peter R., Schilling, Lisa M., Shah, Karishma, Shah, Nigam H., Subbian, Vignesh, Zhang, Lin, Zhu, Hong, Ryan, Patrick, Prieto-Alhambra, Daniel, Kostka, Kristin, Duarte-Salles, Talita

“…Background A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the…”
Get full text

Diabetes mellitus and its correlates in an Iranian adult population by Golozar, Asieh, Khademi, Hooman, Kamangar, Farin, Poutschi, Hossein, Islami, Farhad, Abnet, Christian C, Freedman, Neal D, Taylor, Philip R, Pharoah, Paul, Boffetta, Paolo, Brennan, Paul J, Dawsey, Sanford M, Malekzadeh, Reza, Etemadi, Arash

“…The rising epidemic of diabetes imposes a substantial economic burden on the Middle East. Using baseline data from a population based cohort study, we aimed to…”
Get full text

Does Metformin Reduce Cancer Risks? Methodologic Considerations by Golozar, Asieh, Liu, Shuiqing, Lin, Joeseph A., Peairs, Kimberly, Yeh, Hsin-Chieh

“…The substantial burden of cancer and diabetes and the association between the two conditions has been a motivation for researchers to look for targeted…”
Get full text

Predictive Models for Assessing Patients’ Response to Treatment in Metastatic Prostate Cancer: A Systematic Review by Lawlor, Ailbhe, Lin, Carol, Gómez Rivas, Juan, Ibáñez, Laura, Abad López, Pablo, Willemse, Peter-Paul, Imran Omar, Muhammad, Remmers, Sebastiaan, Cornford, Philip, Rajwa, Pawel, Nicoletti, Rossella, Gandaglia, Giorgio, Yuen-Chun Teoh, Jeremy, Moreno Sierra, Jesús, Golozar, Asieh, Bjartell, Anders, Evans-Axelsson, Susan, N'Dow, James, Zong, Jihong, Ribal, Maria J., Roobol, Monique J., Van Hemelrijck, Mieke, Beyer, Katharina

“…Existing predictive models for men diagnosed with metastatic prostate cancer are not suitable for use due to a lack of model performance and external…”
Get full text

Genetic variants in sex hormone metabolic pathway genes and risk of esophageal squamous cell carcinoma by Hyland, Paula L, Freedman, Neal D, Hu, Nan, Tang, Ze-Zhong, Wang, Lemin, Wang, Chaoyu, Ding, Ti, Fan, Jin-Hu, Qiao, You-Lin, Golozar, Asieh, Wheeler, William, Yu, Kai, Yuenger, Jeff, Burdett, Laurie, Chanock, Stephen J, Dawsey, Sanford M, Tucker, Margaret A, Goldstein, Alisa M, Abnet, Christian C, Taylor, Philip R

“…In China, esophageal cancer is the fourth leading cause of cancer death where essentially all cases are histologically esophageal squamous cell carcinoma…”
Get full text

Comparison of Two Quantitative Approaches to Diagnose Fredrickson-Levy-Lees Dyslipidemias by Sathiyakumar, Vasanth, MD, Sniderman, Allan, MD, Jones, Steven, MD, Golozar, Asieh, MD, PhD, Seth Martin, MD, MHS, FACC

Get full text

Methods to identify and prioritize patient-centered outcomes for use in comparative effectiveness research by Mayo-Wilson, Evan, Golozar, Asieh, Cowley, Terrie, Fusco, Nicole, Gresham, Gillian, Haythornthwaite, Jennifer, Tolbert, Elizabeth, Payne, Jennifer L, Rosman, Lori, Hutfless, Susan, Canner, Joseph K, Dickersin, Kay

“…We used various methods for identifying and prioritizing patient-centered outcomes (PCOs) for comparative effectiveness research (CER). We considered potential…”
Get full text

82. Enabling large scale precision oncology research with a new standard for genomic variants: OMOP Genomic by Golozar, Asieh, Reich, Christian

Get full text

RE: "An Estimation of the Risk of Pseudotumor Cerebri Among Users of the Levonorgestrel Intrauterine Device" by Golozar, Asieh, Schoendorf, Juliane

“…The current letter to the editor describes some of the limitations of Valenzuela et al.'s study on the association between levonorgestrel-releasing…”
Get full text

Estimation of adverse drug reaction reporting in Iran: Correction for underreporting by Khalili, Malahat, Mesgarpour, Bita, Sharifi, Hamid, Golozar, Asieh, Haghdoost, Ali Akbar

“…Propose Underreporting of Adverse Drug Reactions (ADRs) reduces the sensitivity of pharmacovigilance systems. We described ADR reporting and its trend from…”
Get full text

Epidemiological and clinical characteristics of cancer patients with COVID-19: A systematic review and meta-analysis of global data by Kong, Xiangyi, Qi, Yihang, Huang, Junjie, Zhao, Yang, Zhan, Yongle, Qin, Xuzhen, Qi, Zhihong, Atanda, Adejare (Jay), Zhang, Lei, Wang, Jing, Fang, Yi, Jia, Peng, Golozar, Asieh, Zhang, Lin, Jiang, Yu

“…There are minimal data regarding the prevalence of cancer in patients with coronavirus disease 2019 (COVID-19), as well as the incidence of severe illness and…”
Get full text

Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study by Burn, Edward, You, Seng Chan, Sena, Anthony G., Kostka, Kristin, Abedtash, Hamed, Abrahão, Maria Tereza F., Alberga, Amanda, Alghoul, Heba, Alser, Osaid, Alshammari, Thamir M., Aragon, Maria, Areia, Carlos, Banda, Juan M., Cho, Jaehyeong, Culhane, Aedin C., Davydov, Alexander, DeFalco, Frank J., Duarte-Salles, Talita, DuVall, Scott, Falconer, Thomas, Fernandez-Bertolin, Sergio, Gao, Weihua, Golozar, Asieh, Hardin, Jill, Hripcsak, George, Huser, Vojtech, Jeon, Hokyun, Jing, Yonghua, Jung, Chi Young, Kaas-Hansen, Benjamin Skov, Kaduk, Denys, Kent, Seamus, Kim, Yeesuk, Kolovos, Spyros, Lane, Jennifer C. E., Lee, Hyejin, Lynch, Kristine E., Makadia, Rupa, Matheny, Michael E., Mehta, Paras P., Morales, Daniel R., Natarajan, Karthik, Nyberg, Fredrik, Ostropolets, Anna, Park, Rae Woong, Park, Jimyung, Posada, Jose D., Prats-Uribe, Albert, Rao, Gowtham, Reich, Christian, Rho, Yeunsook, Rijnbeek, Peter, Schilling, Lisa M., Schuemie, Martijn, Shah, Nigam H., Shoaibi, Azza, Song, Seokyoung, Spotnitz, Matthew, Suchard, Marc A., Swerdel, Joel N., Vizcaya, David, Volpe, Salvatore, Wen, Haini, Williams, Andrew E., Yimer, Belay B., Zhang, Lin, Zhuk, Oleg, Prieto-Alhambra, Daniel, Ryan, Patrick

“…Comorbid conditions appear to be common among individuals hospitalised with coronavirus disease 2019 (COVID-19) but estimates of prevalence vary and little is…”
Get full text

Outcomes in patients (pts) with advanced basal cell carcinoma (aBCC) who discontinued hedgehog inhibitors (HHI) as first-line (1L) systemic treatment (Tx) in a U.S. community oncology setting: A retrospective observational study by Cowey, Charles Lance, Chen, Chieh-I, Aguilar, Kathleen M., Davies, Kalatu, LaFontaine, Patrick R., Fury, Matthew G., Bowler, Timothy Geoffrey, Jalbert, Jessica J., Golozar, Asieh

“…Abstract only e18742 Background: HHIs are the only approved 1L systemic Tx for aBCC. Many pts develop resistance or are intolerant to HHIs and may require…”
Get full text

Frequency, characteristics, and subsequent treatment (Tx) of real-world patients (pts) who discontinue hedgehog inhibitors (HHIs) as first-line (1L) systemic Tx for advanced basal cell carcinoma (aBCC) by Cowey, Charles Lance, Chen, Chieh-I, Aguilar, Kathleen M., Davies, Kalatu, LaFontaine, Patrick R., Fury, Matthew G., Bowler, Timothy Geoffrey, Golozar, Asieh, Jalbert, Jessica J.

“…Abstract only e18740 Background: HHIs are the only approved 1L systemic Tx for aBCC and Tx options following HHI Tx failure are limited. The objective of this…”
Get full text